PharmaJet Archives - Page 3 of 4

Developments

University of Cambridge begins COVID-19 trial with PharmaJet needle-free system

PharmaJet’s needle-free Injection system will be used in a clinical trial to deliver a booster vaccine against COVID-19 virus variants. The vaccine developed by DIOSynVax, a spinoff company supported by the University...

January 18, 2022

Developments

PharmaJet partner Zydus Cadila in COVID-19 vaccine expansion with Korean firm

Needle-free injection company PharmaJet’s partner, Zydus Cadila, is partnering with Enzychem Lifesciences to manufacture their COVID-19 plasmid DNA vaccine, ZyCoV-D, in Korea. The plan is to manufacture more than 80...

January 4, 2022

Developments

PharmaJet, WHO, Gates Foundation in Somalia polio vaccination campaign

Closely-held PharmaJet’s Tropis intradermal needle-free injection system is being used in a campaign in Somalia, delivering inactivated polio vaccine to more than 110,000 children. The purpose of the campaign, funded in...

October 21, 2021

Developments

PharmaJet to deliver Scancell COVID-19 DNA vaccines

Closely-held PharmaJet was selected by partner, Scancell, to administer its two SARS-CoV-2 DNA vaccine candidates, SCOV1 and SCOV2, using the PharmaJet Tropis and PharmaJet Stratis Needle-free injection...

September 14, 2021

Developments

PharmaJet needle free system cleared for first plasmid DNA COVID-19 vaccine

Closely-held PharmaJet announced that its partner, Zydus Cadila, has received Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D, the world’s first plasmid DNA vaccine for...

August 23, 2021

Executive Moves

PharmaJet names Paul LaBarre as VP global business development

Paul LaBarre PharmaJet named Paul LaBarre as VP of global business development to lead business development and commercialization strategies, replacing Melissa Malhame, who transitioned to a strategic advisory role for...

June 15, 2021

Developments

Lancet article discusses benefits of PharmaJet Tropis ID needle-free delivery

A systematic review and meta-analysis published in the April 30, 2021 issue of The Lancet strengthens evidence that fractional dose delivery is a viable alternative to full dose inactivated polio vaccine (IPV) and...

June 3, 2021

Executive Moves

PharmaJet names Marian Wentworth to board

Marian Wentworth Closely-held PharmaJet appointed Marian Wentworth, president and CEO of Management Sciences for Health since 2017, to its board. Management Sciences for Health is a non-profit organization that works...

February 9, 2021

Developments

PharmaJet partners with Diomics to detect SARS-CoV-2 immune response

Closely-held PharmaJet’s needle-free injection system will be used to deliver Diomics’ Diocheck SARS-CoV-2 visual immune response indicator. Diomics’ immune response indicator will be injected under the skin using...

November 17, 2020

Executive Moves

PharmaJet appoints Melissa Malhame as VP business development

Melissa Malhame Closely-held PharmaJet appointed Melissa Malhame as its VP of business development, where she will lead the company’s business development, sales, and marketing operations. “[Ms. Malhame’s] strategic...

September 29, 2020

Tag - PharmaJet

University of Cambridge begins COVID-19 trial with PharmaJet needle-free system

PharmaJet partner Zydus Cadila in COVID-19 vaccine expansion with Korean firm

PharmaJet, WHO, Gates Foundation in Somalia polio vaccination campaign

PharmaJet to deliver Scancell COVID-19 DNA vaccines

PharmaJet needle free system cleared for first plasmid DNA COVID-19 vaccine

PharmaJet names Paul LaBarre as VP global business development

Lancet article discusses benefits of PharmaJet Tropis ID needle-free delivery

PharmaJet names Marian Wentworth to board

PharmaJet partners with Diomics to detect SARS-CoV-2 immune response

PharmaJet appoints Melissa Malhame as VP business development

Subscribe